Alerts will be sent to your verified email
Verify Email
BROOKS
|
Brooks Laboratories
|
Lyka Labs
|
Trident Lifeline
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-21.13 % | 62.44 % | 31.52 % |
|
5yr average Equity Multiplier
|
1.68 | 2.9 | 2.03 |
|
5yr Average Asset Turnover Ratio
|
0.62 | 0.73 | 0.82 |
|
5yr Avg Net Profit Margin
|
-21.45 % | -0.79 % | 16.21 % |
|
Price to Book
|
3.34 | 3.26 | 5.34 |
|
P/E
|
0.0 | 45.01 | 29.26 |
|
5yr Avg Cash Conversion Cycle
|
23.75 Days | 32.55 Days | 61.09 Days |
|
Inventory Days
|
83.11 Days | 24.2 Days | 72.84 Days |
|
Days Receivable
|
80.26 Days | 92.33 Days | 86.3 Days |
|
Days Payable
|
163.46 Days | 106.74 Days | 122.66 Days |
|
5yr Average Interest Coverage Ratio
|
-11.18 | 2.2 | 14.53 |
|
5yr Avg ROCE
|
-11.18 % | 25.83 % | 26.3 % |
|
5yr Avg Operating Profit Margin
|
-10.26 % | 24.02 % | 16.98 % |
|
5 yr average Debt to Equity
|
0.18 | 1.25 | 0.47 |
|
5yr CAGR Net Profit
|
-12.45 % | n/a | 24.36 % |
|
5yr Average Return on Assets
|
-13.31 % | 1.72 % | 13.79 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.62 % | 58.16 % | 63.11 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 3.43 % |
|
Change in Promoter Holding (3 Yrs)
|
-13.79 % | 10.57 % | -6.46 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
9.9 % | -3.53 % | 0.0 |
|
Brooks Laboratories
|
Lyka Labs
|
Trident Lifeline
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|